Urs Brändli
Chief Tech/Sci/R&D Officer chez DOTTIKON ES HOLDING AG
Fortune : 1 M $ au 31/03/2024
Profil
Urs Brändli est responsable des processus et des technologies chez Dottikon Es Holding AG.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
DOTTIKON ES HOLDING AG
0,03% | 31/03/2023 | 4 050 ( 0,03% ) | 1 M $ | 31/03/2024 |
Postes actifs de Urs Brändli
Sociétés | Poste | Début |
---|---|---|
DOTTIKON ES HOLDING AG | Chief Tech/Sci/R&D Officer | 01/01/2003 |
Dottikon Exclusive Synthesis AG
Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. | Corporate Officer/Principal | - |
Dottikon Es Management AG | Corporate Officer/Principal | - |
Swiss Chemical Society
Swiss Chemical Society Miscellaneous Commercial ServicesCommercial Services Swiss Chemical Society provides accounting services. The non-profit company is based in Bern, Switzerland. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
DOTTIKON ES HOLDING AG | Process Industries |
Entreprise privées | 3 |
---|---|
Swiss Chemical Society
Swiss Chemical Society Miscellaneous Commercial ServicesCommercial Services Swiss Chemical Society provides accounting services. The non-profit company is based in Bern, Switzerland. | Commercial Services |
Dottikon Exclusive Synthesis AG
Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. | Health Technology |
Dottikon Es Management AG |